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Leukocyte transendothelial migration and sequestration are two distinct outcomes following leukocyte adhesion to endotheli-
um during ischemia-reperfusion injury, in which platelets may play a pivotal role. In the present study, we established an in 
vitro hypoxia-reoxygenation model to mimic ischemia-reperfusion injury and found platelet pre-incubation significantly in-
creased leukocyte adhesion to endothelial cells after hyoxia-reoxygenation (over 67%). Blockade of endothelial-cell-expressed 
adhesion molecules inhibited leukocyte direct adhesion to endothelial cells, while platelet-mediated leukocyte adhesion was 
suppressed by blockade of platelet-expressed adhesion molecules. Further experiments revealed platelets acted as a bridge to 
mediate leukocyte adhesion, and platelet-mediated adhesion was the predominant pattern in the presence of platelets. However, 
platelet pre-incubation significantly suppressed leukocyte transendothelial migration after hypoxia-reoxygenation (over 31%), 
which could be aggravated by blockade of endothelial-cell-expressed adhesion molecules, but alleviated by blockade of plate-
let-expressed adhesion molecules. This would indicate that platelet-mediated adhesion disrupted leukocyte transendothelial 
migration. An in vivo mesenteric ischemia-reperfusion model demonstrated leukocyte transfusion alone caused mild leukocyte 
adhesion to reperfused vessels and subsequent leukocyte infiltration, while simultaneous leukocyte and platelet transfusion led 
to massive leukocyte adhesion and sequestration within reperfused microvessels. Our studies revealed platelets enhanced leu-
kocyte adhesion to endothelial cells, but suppressed leukocyte transendothelial migration. Overall, this leads to leukocyte se-
questration in hypoxia-reoxygenated microvessels. 
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During an inflammatory response, leukocytes are first re-
cruited to the site of injury and then adhere to the endothe-
lium (Muller, 2011). However, subsequent consequences 
may vary. In some conditions or diseases, for example, 
multiple sclerosis, most leukocytes transmigrate through the 
endothelial barrier and infiltrate into the adjacent tissues, 
causing lesions in the affected area (Compston and Coles, 
2008). On the contrary, as in cerebral malaria, a few leuko-
cytes transmigrate through the endothelium, but most are 
sequestrated within the microvessels, thus inducing local 
ischemia (Coltel et al., 2004; Pai et al., 2014). Yet, the rea-
sons leading to leukocyte transmigration or sequestration in 
different conditions are poorly understood. 
Ischemia-reperfusion (I-R) injury is a common complica-
tion during ischemic disease therapy and organ transplanta-
tion, in which leukocytes infiltrate into reperfused tissues 
and cause tissue lesions (Francischetti et al., 2010). Both 
leukocyte transendothelial migration (TEM) and sequestra-
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tion can be observed in I-R injury. After reperfusion, a vari-
ety of bioactive substances, especially chemokines, are 
produced. This leads to the recruitment of leukocytes to the 
site of ischemia (Muller, 2013). Leukocytes roll over and 
adhere to the vascular endothelium, then transmigrate 
through the endothelial barrier and infiltrate into the is-
chemic tissues, thus releasing reactive oxygen species and 
cytokines, which can cause cell death and tissue damage 
(Francischetti et al., 2010; Maroszynska and Fiedor, 2000). 
Alternatively, in some circumstances, leukocytes are ag-
gregated within the reperfused microvasculature, impairing 
microcirculation. This happening is referred to as no-reflow 
phenomenon (Kaul, 2014). The underlying forces leading to 
such different outcomes still remain unclear. However, the 
treatment of the monoclonal antibody against the leukocyte 
adhesion molecule alleviates I-R injury and reduces the 
no-reflow incidence (Duilio et al., 2001). The interventions 
against adhesion molecules on endothelial cells (ECs) also 
exhibit beneficial effects (Dulkanchainun et al., 1998; 
Garcia-Criado et al., 1995; Tsuchihashi et al., 2006; Wong 
et al., 1997). These results suggest that leukocyte adhesion 
to the endothelium is the initial power behind leukocyte 
TEM or sequestration. 
Besides leukocytes, platelets also actively participate in 
I-R injury. Significantly increased amounts of platelets ad-
here to endothelium during I-R and the depletion of plate-
lets diminishes the extent of I-R injury (Pak et al., 2010). 
Interestingly, there is a synergistic relationship between 
leukocytes and platelets. Simultaneous reperfusion of plate-
lets and leukocytes aggravates I-R injury more than does 
reperfusion of platelets or leukocytes alone (Sindram et al., 
2001). It is noteworthy that platelets express various kinds 
of adhesion molecules which mediate the adhesion of plate-
lets to numerous cell types. Such cell types include leuko-
cytes and ECs (Ruggeri and Mendolicchio, 2007). Upon 
stimulation, these adhesion molecules are transported to the 
platelet surface and become activated (Ruggeri et al., 2006). 
Since both TEM and sequestration of leukocytes rely on its 
adhesion to the endothelium, platelets may have a great im-
pact in determining leukocyte TEM or sequestration. In the 
present study, we examined the effects of platelets on leu-
kocyte adhesion to ECs and TEM. We attempted to reveal 
the role of platelets in the determination of leukocyte TEM 
or sequestration in hypoxia-reoxygenation (H-R) condition. 
RESULTS 
The effects of platelets on leukocyte adhesion to ECs 
after H-R 
First, we examined the effects of platelets on leukocyte ad-
hesion to ECs. In our experiments, we employed primary 
cultured human brain endothelial cells (HBECs) and human 
lung endothelial cells (HLECs), immortalized liver sinusoi-
dal endothelial cell (LSEC) line, leukocytes and platelets 
freshly isolated from peripheral blood. In a resting state 
without an H-R treatment, the leukocytes rarely adhered to 
ECs either with or without platelets. However, after the H-R 
treatment, the leukocyte adhesion was enormously in-
creased compared with that of the resting groups. In the 
H-R-treated groups with platelet pre-incubation, leukocyte 
adhesion was further enhanced compared with that in the 
H-R groups without platelet pre-incubation (Figure 1A and 
B). This phenomenon was observed in all three kinds of 
ECs, indicating it was common for platelets to enhance 
leukocyte adhesion to ECs after an H-R treatment.  
We further examined the adhesion molecules responsible 
for leukocyte adhesion under the H-R condition with or 
without platelets. We selected typical adhesion molecules 
expressed on ECs or platelets as blocking targets, namely 
CD36, intercellular adhesion molecule-1 (ICAM-1), vascu-
lar cell adhesion molecule-1 (VCAM-1), endothelial leuko-
cyte adhesion molecule-1 (ELAM-1), glycoprotein Ib 
(gpIb), glycoprotein IIb (gpIIb), glycoprotein IIIa (gpIIIa), 
P-selectin, and CD31. In the H-R condition without plate-
lets, the antibody against ICAM-1, VCAM-1, ELAM-1, 
P-selectin, or CD31 significantly inhibited the adhesion of 
leukocytes to ECs, while CD36, gpIb, gpIIb, or gpIIIa 
blockade showed no significant effects (Figure 1C). In the 
H-R condition with platelets, the antibody against gpIb, 
gpIIb, gpIIIa, P-selectin, or CD31 significantly inhibited the 
adhesion of leukocytes to ECs, while CD36, ICAM-1, 
VCAM-1, or ELAM-1 blockade showed no significant ef-
fects (Figure 1D).  
The platelet adhesion to LSECs or leukocytes after H-R 
Platelets altered the relevant adhesion molecules mediating 
leukocyte adhesion to ECs. To reveal the underlying mech-
anism, we further examined platelet adhesion to ECs or 
leukocytes respectively. After the H-R treatment, the plate-
let adhesion to LSECs was significantly increased compared 
with that of the resting group (fluorescence intensity: 
(142.1±7.5) of the resting versus (289.2±20.0) of the H-R 
group; Figure 2A and B). The platelet adhesion to leuko-
cytes was also enhanced after the H-R treatment (mean flu-
orescence intensity: (5,550±1,570) of the resting versus 
(14,028±2,019) of the H-R group; Figure 2C and D). The 
adhesion molecule blockade of gpIb, gpIIb, gpIIIa, P-selectin, 
or CD31 significantly inhibited platelet adhesion to LSECs, 
but the antibody against CD36, ICAM-1, VCAM-1, or 
ELAM-1 exhibited no significant effects (Figure 2E). More-
over, the relevant adhesion molecules responsible for platelet- 
leukocyte adhesion were gpIb, gpIIb, gpIIIa, and P-selectin 
(Figure 2F). These results indicated that the positive effects 
of platelets on leukocyte adhesion to ECs might be due to the 
enhancement of platelet adhesion to ECs and leukocytes, with 
platelets acting as an intermediary bridge. 
The morphological evidences for leukocyte adhesion to 
ECs 
To confirm the intermediary role of platelets, we intensively 
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Figure 1  The effects of platelets on leukocyte adhesion to ECs after hypoxia-reoxygenation (H-R). A, Observation of the adhesion of BCECF-labeled- 
leukocytes to human brain endothelial cells (HBECs), human lung endothelial cells (HLECs) and liver sinusoidal endothelial cells (LSECs) under a fluores-
cence microscope (×100; green fluorescence denoted leukocytes and PLT indicated platelet). B, The fluorescence intensity of the adherent leukocytes (**, 
P<0.01, the H-R group versus the resting group; ##, P<0.01, the H-R (PLT) group versus the H-R group; n=3). C, The effects of the adhesion molecule 
blockade on the adhesion of leukocytes to ECs without platelets after H-R (**, P<0.01, the antibody group versus the IgG group; n=3). D, The effects of the 
adhesion molecule blockade on the adhesion of leukocytes to ECs with platelet pre-incubation after H-R (**, P<0.01, the antibody group versus the IgG 
group; n=3).  
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Figure 2  The platelet adhesion to LSECs or leukocytes after H-R. A, The adhesion of BCECF-labeled-platelets to a confluent LSEC monolayer observed 
by a fluorescence microscope (×100; green fluorescence denoted platelets). B, The fluorescence intensity of the adherent platelets (**, P<0.01 compared 
with the resting group; n=3). C, The flow cytometry analysis of the adherent BCECF-labeled platelets to leukocytes after H-R. The leukocytes without plate-
let incubation were employed as a negative control. D, The mean fluorescence intensity of the adherent BCECF- labeled platelets to leukocytes after H-R (**, 
P<0.01 compared with the resting group; n=3). E, The effects of the adhesion molecule blockade on the adhesion of platelets to LSECs after H-R (**, 
P<0.01, the antibody group versus the IgG group; n=3). F, The effects of the adhesion molecule blockade on the adhesion of platelets to leukocytes after H-R 
(**, P<0.01, the antibody group versus the IgG group; n=3).  
observed leukocyte adhesion to ECs under a confocal or a 
transmission electron microscope. Under the H-R condition 
without platelets, the leukocytes directly adhered to the 
LSEC, as the confocal microscope observation evidenced 
(Figure 3A). However, under the H-R condition with plate-
lets, considerably more leukocytes adhered to the LSEC 
(adherent leukocyte number: (2.4±1.1) of the H-R versus 
(6.8±0.8) of the H-R (PLT) group; Figure 3A and B), and 
the majority of leukocyte adhesion was mediated by plate-
lets (percentage of direct adhesion in the H-R (PLT) group: 
(25.6%±8.9%); Figure 3A and C). Further observation by 
an electron microscope also revealed that the leukocyte ad-
hered to a LSEC by direct contact in the absence of platelets 
(Figure 3D). Conversely, under the H-R condition with 
platelets, the platelets protruded pseudopodia connecting the 
leukocyte and LSEC to mediate their adhesion. This re-
vealed the intermediary role of platelets in mediating leu-
kocyte adhesion to ECs (Figure 3D). 
The effects of platelets on leukocyte TEM after H-R 
Leukocyte adhesion to ECs is a preliminary step before 
leukocyte TEM. We next tried to reveal the effects of the 
platelet-enhanced leukocyte adhesion on leukocyte TEM 
after H-R. In a resting state, few leukocytes transmigrated 
through the EC layer no matter whether platelets were pre-
sent or not. After the H-R treatment, significantly increased 
amounts of transmigrated leukocytes were observed in the 
groups without platelets compared to those in the groups of 
the resting state. However, in the H-R groups with platelet 
pre-incubation, the transmigrated leukocytes were signifi-
 Zheng, S., et al.   Sci China Life Sci   March (2016) Vol.59 No.3 303 
 
Figure 3  The morphological evidences for leukocyte adhesion to ECs. A, Observation of the leukocyte adhesion to LSEC under a laser scanning confocal 
microscope after H-R (×1,800). The platelets were labeled with CM-DiI (red) and the leukocytes were labeled with BCECF (green). B, Quantification of the 
adherent leukocytes to a single LSEC (**, P<0.01 compared with the H-R group; n=5). C, Ratio of the direct adherent leukocytes to the total adherent leu-
kocytes (**, P < 0.01 compared with the H-R group; n=5). D, The transmission electron microscope images of the leukocyte adhesion to LSEC after H-R 
(×8,000).  
cantly fewer than those in the H-R groups without platelets 
(Figure 4A and B). Moreover, we examined the effects of 
adhesion molecule blockade on leukocyte TEM after the 
exposure to H-R. In the H-R groups without platelets, the 
antibody against ICAM-1, VCAM-1, ELAM-1, P-selectin, 
or CD31 significantly inhibited leukocyte TEM, while the 
antibody against CD36, gpIb, gpIIb, or gpIIIa showed no 
significant effects (Figure 4C). In the H-R groups with 
platelets, the antibody against ICAM-1, VCAM-1, or 
ELAM-1 further inhibited leukocyte TEM. On the other 
hand, the antibody against gpIb, gpIIb, or gpIIIa promoted 
leukocyte TEM, whereas the antibody against CD36, 
P-selectin, or CD31 exhibited no significant effects (Figure 
4D). 
The effects of platelets on leukocyte adhesion and TEM 
in ischemic-reperfused vessels in vivo  
In vitro experiments demonstrated that platelets enhanced 
leukocyte adhesion to ECs but suppressed leukocyte TEM. 
To confirm the in vitro results, we conducted a series of in 
vivo experiments assessing the effects of platelets on adhe-
sion and TEM of leukocytes in the I-R injury model. 
Healthy SD rats were employed to establish I-R in jejunum. 
After injecting the BCECF-labeled leukocytes with or 
without CM-DiI-labeled platelet pre-incubation, 10 min 
(acute) or 12 h (subacute) reperfusion was allowed. In the 
acute model, the injected leukocytes seldom adhered to 
mesenteric vessels regardless of whether platelets were in-
jected or not in the non-ischemic area (Figure 5A). Con-
versely, in the I-R area, leukocyte transfusion alone caused 
sporadic leukocyte adhesion, but the simultaneous transfu-
sion of leukocytes and platelets induced massive leukocyte 
adhesion to the reperfused vessels (Figure 5A). Further-
more, in the subacute model, nearly no labeled leukocytes 
were found in the normoxia area (Figure 5B). In the I-R 
area, sporadic labeled leukocytes were distributed in the 
adjacent tissues rather than within the vessels after leuko-
cyte transfusion alone, indicating that leukocyte TEM was 
the main outcome. Conversely, large amounts of labeled 
leukocytes were located within the reperfused vessels after 
the simultaneous transfusion of leukocytes and platelets. 
This revealed that platelets inhibited leukocyte TEM and 
induced leukocyte sequestration within the microvessels 
(Figure 5B). It was worthy of attention that the labeled 
platelets were co-localized with the labeled leukocytes after 
the simultaneous transfusion, thus confirming the interme-
diary role of platelets (Figure 5A and B). 
DISCUSSION 
In the present study, we provided three concepts confirmed 
by our experiments: (i) Platelets promoted leukocyte adhe-
sion to ECs under H-R condition; (ii) platelets suppressed 
leukocyte TEM under H-R condition; (iii) platelets exerted 
a critical action in determining leukocyte TEM or seques-
tration in I-R injury. 
In our experiments, the influence of platelets on leuko-
cyte adhesion to ECs was demonstrated in three types of 
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Figure 4  The effects of platelets on leukocyte TEM after H-R. A, Observation of the transmigrated leukocytes through the endothelial cell layer under a 
fluorescence microscope (×100; green fluorescence denoted leukocytes). B, Quantification of the fluorescence intensity of the transmigrated leukocytes (**, 
P<0.01, the H-R group versus the resting group; ##, P<0.01, the H-R (PLT) group versus the H-R group; n=3). C, The effects of the adhesion molecule 
blockade on leukocyte TEM without platelets after H-R (*, P<0.05; **, P<0.01, the antibody group versus the IgG group; n=3). D, The effects of the adhe-
sion molecule blockade on leukocyte TEM with platelet pre-incubation after H-R (*, P<0.05; **, P<0.01, the antibody group versus the IgG group; n=3). 
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Figure 5  The effects of platelets on leukocyte adhesion and TEM in ischemic-reperfused vessels in vivo. The leukocytes were labeled with green fluores-
cent dye BCECF, and the platelets were labeled with red fluorescent dye CM-DiI. The H-R-treated leukocytes incubated with or without platelets were in-
jected into the jejunal artery after one of its branches suffered ischemia for 30 min. A, In the acute model (10 min after the transfusion), the leukocyte or 
platelet distribution was demonstrated by green or red fluorescence in the normoxia or ischemia-reperfused area (n=10). B, In the subacute model (12 h after 
the transfusion), the leukocyte or platelet distribution was demonstrated by green or red fluorescence in the normoxia or ischemia-reperfused area (n=10). 
ECs, two of primary cultured ECs and one immortalized 
endothelial cell line. In all three kinds of ECs, platelets fur-
ther enhanced the H-R-induced leukocyte adhesion to ECs. 
In some cases other than I-R injury, there are also reports 
concerning platelet-dependent leukocyte adhesion. During 
the development of atherosclerosis, platelets adhere to the 
endothelium prone to injury and enhance the capability of 
endothelium to recruit leukocytes, thus contributing to ath-
erosclerosis formation (Huo et al., 2003; May et al., 2007). 
The lymphocyte delivery to high endothelial venules also 
depends on platelet-induced adhesion (Diacovo et al., 
1996a). A similar phenomenon is observed in inflamed 
brain microvessels, where leukocyte adhesion is mediated 
by platelets (Carvalho-Tavares et al., 2000). However, pre-
vious reports favor the view that platelets preferentially ad-
here to the subendothelial matrix, mediating the adhesion of 
leukocytes to the exposed subendothelial matrix rather than 
to ECs (Diacovo et al., 1996b; Kuijper et al., 1996). When 
our studies revealed that platelets enhanced leukocyte adhe-
sion to ECs after the H-R treatment, we then focused on  
the differences of direct leukocyte adhesion and platelet- 
mediated leukocyte adhesion. 
The adhesion of leukocytes to ECs is mediated by adhe-
sion molecules, and the typical adhesion molecules we se-
lected were expressed on ECs, such as ICAM-1, VCAM-1, 
and ELAM-1, or expressed on platelets, including gpIb, 
gpIIb, and gpIIIa, or even expressed on both (CD36, 
P-selectin, and CD31) (Zabel et al., 2015). CD36 showed no 
significant effects in any process in our study, indicating it 
did not participate in leukocyte adhesion or TEM. Except 
for CD36, it was apparent that the adhesion molecules ex-
pressed on ECs took part in leukocyte direct adhesion to 
ECs, while the adhesion molecules expressed on platelets 
participated in the platelet-mediated leukocyte adhesion. 
Further analyses evidenced that platelets adhered to both 
ECs and leukocytes, acting as a bridge to mediate their ad-
hesion. 
It has been reported that the use of H-R can activate ECs, 
enhance adhesion molecules expression, change the activity 
of coagulation and fibrinolysis, and produce cytokines, and 
thus recruit platelets and induce platelet adhesion (Yang   
et al., 2002). The adherent platelets could further fuse into 
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ECs and support endothelium function (Wojcik et al., 
1969), and thus play an important role in tumor necrosis 
factor (TNF)-induced microvascular pathology (Grau et al., 
1993; Lou et al., 1997). Under some pathological conditions 
such as stroke and inflammation induced by cigarette 
smoking, leukocytes are not found as single cells, but as 
aggregates linked by activated platelets (Lehr, 2000; Ritter 
et al., 2005). Other reports find that P-selectin is crucial for 
platelet-leukocyte adhesion. The initial contact between 
platelets and leukocytes is driven by the recognition of 
P-selectin on the platelet surface and P-selectin glycoprotein 
ligand-1 (PSGL-1) on the leukocyte surface. Such circum-
stances can trigger the conformational changes of integrins 
and further augment the adhesive capacity of leukocytes (da 
Costa Martins et al., 2006; Piccardoni et al., 2001). The 
binding of P-selectin to PSGL- 1 could also induce a series 
of inflammatory responses, including nuclear translocation 
of NF-B and the gene expression of various inflammatory 
cytokines, which is essential for the inflammatory pheno-
type acquisition of leukocytes (Dixon et al., 2006; Weyrich 
et al., 1996). The processes of platelet interaction with ECs 
and leukocytes are complicated and involve a great deal of 
conformational and functional alterations, which may con-
tribute to the augmented leukocyte adhesion to ECs.  
According to some traditional viewpoints, the firm adhe-
sion of leukocytes to ECs is necessary for leukocyte TEM 
(Coito, 2011; Muller, 2011). In our studies, the H-R treat-
ment without platelets increased leukocyte adhesion and 
subsequently increased leukocyte TEM. However, the en-
hanced leukocyte adhesion to ECs mediated by platelets did 
not promote, but suppressed leukocyte TEM. As we out-
lined above, previous studies focused on the adhesion of 
platelets and extracellular matrix. It has been reported that 
leukocytes can transmigrate through the platelet layer ad-
hered to coated fibronectin by crosstalk of the adhesion 
molecules. This implies that platelets can facilitate leuko-
cyte transmigration (Diacovo et al., 1996b). Nonetheless, 
leukocyte TEM is a much more complicated process, in-
cluding adhesion molecule activation, cytoskeleton altera-
tion, intercellular junction dissociation, and extracellular 
matrix enzyme secretion (Alcaide et al., 2008; Shaw et al., 
2004; Sternlicht and Werb, 2001; Yang et al., 2006). Plate-
lets may participate in any process and interfere with leu-
kocyte TEM. We found that ICAM-1, VCAM-1, ELAM-1, 
P-selectin, and CD31 were not only significant to leukocyte 
adhesion, but also to leukocyte TEM in the platelet-free 
condition, thus indicating that the direct adhesion of leuko-
cytes to ECs was necessary for leukocyte TEM. We hy-
pothesized that the platelet-mediated adhesion altered some 
functional properties acquired by leukocyte direct adhesion 
to ECs and disrupted the subsequent TEM. Based on this 
hypothesis, the phenomena observed in our studies could be 
explained. Under the H-R condition with platelets, the 
blockade of gpIb, gpIIb, or gpIIIa inhibited the plate-
let-mediated adhesion, and thus competitively increased 
leukocyte direct adhesion to ECs and the subsequent TEM. 
On the contrary, the blockade of ICAM-1, VCAM-1, or 
ELAM-1 further inhibited the leukocyte direct adhesion to 
ECs and suppressed leukocyte TEM. P-selectin and CD31 
participated in both leukocyte direct adhesion and the plate-
let-mediated adhesion, so that the blockade of P-selectin or 
CD31 showed no significant effects, for the counteraction 
of both processes. This hypothesis was consistent with our 
in vitro results, and then we intensively tested the hypothe-
sis in vivo. 
In vivo, a mesenteric I-R model was established, due to 
superficial location and transparency of the mesenteric ves-
sels, which allowed the direct observation of leukocyte dis-
tribution by fluorescent labeling. Since leukocyte adhesion 
was achieved within 10 min and leukocyte TEM occurred 
within 12 h after the initial adhesion (Zabel et al., 2015), the 
two phases were distinguished by the two time points. Leu-
kocyte transfusion alone caused mild leukocyte adhesion in 
the acute phase and leukocyte TEM in the subacute phase. 
However, the simultaneous transfusion of leukocytes and 
platelets induced significant leukocyte adhesion in the acute 
phase and remarkable leukocyte sequestration in the sub-
acute phase. These results were in agreement with our hy-
pothesis and indicated that, at least in our experimental 
conditions, platelets determined the distinct outcomes of 
leukocyte TEM or sequestration. 
Both leukocyte TEM and sequestration are harmful in 
pathological conditions. Leukocyte TEM is the preliminary 
step for leukocyte infiltration, which is the marker of in-
flammatory severity and tissue damage. Leukocyte seques-
tration can obstruct vessel lumen and induce local ischemia. 
Anti-platelet intervention may alleviate leukocyte seques-
tration, but otherwise extend leukocyte infiltration, a condi-
tion which raises concerns for the application of the an-
ti-platelet therapy. The current anti-platelet therapy focuses 
on acute coronary syndromes. In clinical trials, anti-platelet 
drugs (such as aspirin and thienopyridines) can reduce the 
no-reflow occurrence after coronary intervention. Such a 
condition is considered to be attributed to their anti-coagu- 
lation effects (Mehta et al., 2008; Niccoli et al., 2010). Here, 
we demonstrated that the beneficial effects of the an-
ti-platelet treatment might also include its suppression of 
leukocyte adhesion and sequestration. In summary, our 
studies revealed that platelets promoted leukocyte adhesion 
to ECs, but suppressed leukocyte TEM under H-R condi-
tion. The platelet-mediated leukocyte adhesion contributed 
to leukocyte sequestration in the microvasculature during 
the I-R injury (as illustrated in Figure 6). 
MATERIALS AND METHODS 
Main reagents and equipment  
The cells were cultured in Dulbecco’s modified eagle’s me-
dium (DMEM; Gibco, USA), and stained with the fluores
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Figure 6  A schematic diagram of the influence of platelets on leukocyte TEM and sequestration. Under the H-R condition without platelets, the leukocytes 
adhered to ECs and subsequently transmigrated through the endothelium. Under the H-R condition with platelets, the leukocyte adhesion was enhanced, but 
the leukocyte TEM was suppressed, leading to leukocyte sequestration in hypoxia-reoxygenated microvessels. 
cent dye CM-DiI (Invitrogen, USA) or 2′,7′-bis-(2-carbo- 
xyethyl)-5-(and-6)-carboxyfluorescein (BCECF; Invitrogen, 
USA). Human or rat leukocytes were separated by human or 
rat leukocyte isolation kits (TBD Science, China). The mu-
rine monoclonal or polyclonal antibodies had specificity 
against human glycoprotein Ib (gpIb), glycoprotein IIb 
(gpIIb), glycoprotein IIIa (gpIIIa), P-selectin, CD31, CD36 
(Chemicon, USA), intercellular adhesion molecule-1 
(ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), 
and endothelial leukocyte adhesion molecule-1 (ELAM-1) 
(Sigma, USA). The platelets were incubated with 10 nmol L1 
colloidal gold-labeled goat-anti-mouse antibody (Sigma, 
USA) for electron microscope observation. Images were 
acquired by using a fluorescence microscope (Olympus, 
Japan), a laser scanning confocal microscope (Leica, Ger-
many) or a Type JEM 1010 transmission electron micro-
scope (JEOL, Japan). The fluorescence intensity was quan-
tified via a fluorescence plate reader (Molecular Devices, 
USA). The BCECF-labeled platelets adherence to leuko-
cytes was detected by flow cytometry (Becton-Dickinson, 
USA).  
Isolation and purification of microvascular endothelial 
cells from human tissues 
Microvascular endothelial cells of human brains and lungs 
were isolated from autopsy donors without diseases of the 
central nervous system and lungs. The study protocol was 
examined and approved by the Ethical Committee for Re-
search in Humans of China-Japan Friendship Hospital. The 
method for the isolation of microvascular endothelial cells 
was previously described (Wu et al., 2008). In brief, the 
tissues were cut into 2 mm×2 mm pieces and then digested 
in 10 mL of 0.2% collagenase type I (Sigma, USA) for 20 
min at 37°C. The samples were mixed with 5 mL of 0.1% 
trypsin plus 0.1% ethylene diamine tetraacetic acid (EDTA) 
and incubated for 5 min at 37°C. Dulbecco’s modified ea-
gle’s medium (DMED, 20 mL) was then added to stop di-
gestion. After passing through a 200-μm filter, the cell sus-
pension was collected and washed three times with DMEM. 
The pellet was suspended and incubated in DMEM con-
taining 50% fetal bovine serum (FBS) for 5 min to induce 
microvascular endothelial cell aggregation. The cell suspen-
sion was centrifuged at 500×g for 5 min, and the pellet was 
suspended in DMEM containing 2 mmol L1 L-glutamine, 
100 U mL1 penicillin, 100 μg mL1 streptomycin, 20% 
FBS, 100 μg mL1 endothelial cell growth supplement 
(ECGS), and 40 U mL1 heparin. The cells were seeded in a 
6-well plate coated with 2% gelatin type A (Sigma, USA). 
After 3–5 d in culture, the cell colonies achieved the typical 
morphology of an endothelial cell colony. Under a phase 
contract microscope, the non-endothelial cells around the 
EC colonies were weeded out using a glass microtube. The 
remaining cells were digested and then seeded in a 6-well 
plate coated with 2% gelatin type A. The purified human 
endothelial cells at passages 5–8 were used in our study. 
The purity of microvascular endothelial cells was deter-
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mined and reported in our previous studies (Lou et al., 
1998; Zhang et al., 2010b). 
Cell line 
A human liver sinusoidal endothelial cell (LSEC) line was 
established by transfecting primary cultures of human liver 
sinusoidal endothelial cells with simian vacuolating vi-
rus-40T and telomerase reverse transcriptase. The endothe-
lial properties of LSEC were established in earlier investi-
gations (Salmon et al., 2000; Zhang et al., 2010a). 
Isolation and fluorescent labeling of human platelets and 
leukocytes 
The human peripheral blood samples anti-coagulated with 
heparin were obtained from healthy volunteers. In the pro-
cesses of platelet isolation, 1/10 volume of Acid Citrate 
Dextrose (ACD) solution (citric acid 0.038 mol L1, citric 
acid trisodium 0.085 mol L1, and glucose 0.136 mol L1; 
pH=5.03) was added to inhibit platelet activation. The sam-
ples were centrifuged at 270×g for 10 min at room temper-
ature. The supernatant was collected and added to an equal 
volume of ACD solution. The samples were then centri-
fuged at 1,280×g for 10 min at room temperature, and the 
pellet was collected and washed three times with ACD solu-
tion to harvest the platelets. The separated platelets were 
used in the experiments immediately after isolation. Once 
the platelets were activated, a stage which could be distin-
guished by platelet aggregation, the platelets would be dis-
carded to guarantee the platelets remained in a resting state 
before experiments. 
In the processes of leukocyte isolation, leukocytes were 
separated by a human leukocyte isolation kit according to 
the manufacturer’s instructions. In brief, blood samples 
were added above the separation medium layer, and then 
they were centrifuged at 400×g for 20 min at room temper-
ature. Then, the leukocyte layers were collected and mixed 
with washing buffer. The samples were centrifuged at 
250×g for 10 min at room temperature. The leukocyte pellet 
was collected and washed three times with washing buffer. 
The leukocyte samples were analyzed in the Department of 
Laboratory to examine the ratios of distinct leukocyte cell 
types. We chose samples with ratios in the physiologically 
normal range (neutrophils: 50%–70%; lymphocytes: 20%– 
40%; monocytes: 3%–10%; eosinophils: 0.5%–5%) so that 
the experiments could mimic the normal physiological con-
dition. The freshly separated leukocytes were immediately 
utilized in the experiments to avoid leukocyte activation 
caused by long-time storage. 
The isolated platelets and leukocytes were suspended in 
DMEM, and then incubated with the fluorescent dye 
CM-DiI or BCECF (5 μg mL1) at 37°C for 1 h. After three 
washes, the labeled platelets and leukocytes were suspended 
in DMEM for further use. 
Hypoxia-reoxygenation (H-R) model establishment 
The cultured cells were incubated in an atmosphere of 95% 
N2 and 5% CO2 at 37°C for 24 h in a closed container (hy-
poxia), and then they were transferred to an atmosphere of 
95% air and 5% CO2 at 37°C for 2 h (reoxygenation). 
Detection of leukocyte adhesion to endothelial cells 
The human brain endothelial cells (HBECs), human lung 
endothelial cells (HLECs) and liver sinusoidal endothelial 
cells (LSECs) were seeded on a 96-well plate and grew to 
confluence. In the experiments without platelets, the endo-
thelial cells were treated with H-R, then BCECF-labeled- 
leukocytes were added (leukocyte:endothelial cell=10:1), 
and the mixture was co-incubated for 30 min. The non-  
adherent leukocytes were removed by three-fold washing. 
In the experiments with platelets, the endothelial cells were 
treated with H-R, then platelets were added, and the mixture 
was co-incubated for 4 h (platelet:endothelial cell=3,000:1). 
The non-adherent platelets were removed by washing three 
times. BCECF-labeled leukocytes were added (leuko-
cyte:endothelial cell=10:1) and co-incubated for 30 min, 
then the non-adherent leukocytes were removed by washing 
three times. Cell adhesion images were acquired by a fluo-
rescence microscope and the fluorescence intensity was 
measured by a fluorescence plate reader. The groups with-
out H-R treatment were set as controls. 
In the antibody blocking experiments, endothelial cells 
were incubated with mouse anti-human gpIb, gpIIb, gpIIIa, 
P-selectin, CD31, CD36, ICAM-1, VCAM-1, or ELAM-1 
antibody (final concentration=5 μg mL1) before the co- 
culture with platelets or leukocytes. The control groups 
were incubated with unrelated IgG. 
Detection of platelet adhesion to LSECs 
The LSECs were inoculated in a 96-well plate and grew to 
confluence. After the LSECs were subjected to an H-R 
treatment, BCECF-labeled platelets were added (plate-
let:LSEC=3,000:1) and co-incubated with H-R-treated 
LSECs for 4 h. After three washes, the non-adherent plate-
lets were removed. The images were recorded by a fluores-
cence microscope, and the fluorescence intensity was 
measured by a fluorescence plate reader. The LSECs grown 
in normoxia condition were set as a control.  
In the antibody blocking experiments, mouse anti-human 
gpIb, gpIIb, gpIIIa, P-selectin, CD31, CD36, ICAM-1, 
VCAM-1, or ELAM-1 antibody was incubated with LSECs 
before the platelets were added (final concentration=5    
μg mL1). The control groups were incubated with unrelated 
IgG.  
Detection of platelet adhesion to leukocytes  
The leukocytes were subjected to an H-R treatment and then 
were co-incubated with BCECF-labeled platelets (plate-
let:leukocyte=3,000:1) for 4 h. The samples were centri-
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fuged at 270×g for 10 min at room temperature, and the 
non-adherent platelet supernatants were discarded. After 
three times of centrifugation and suspension, the pellet was 
suspended for a flow cytometry analysis. The leukocytes 
grown under normoxia condition were set as a normal con-
trol, and the leukocytes without platelet incubation were set 
as a negative control. 
In the antibody blocking experiments, mouse anti-human 
gpIb, gpIIb, gpIIIa, P-selectin, CD31, CD36, ICAM-1, 
VCAM-1, or ELAM-1 antibody was incubated with leuko-
cytes before the platelets were added (final concentration=  
5 μg mL1). The control groups were incubated with unre-
lated IgG. 
Morphological observation of the leukocyte adhesion to 
LSECs 
In the laser scanning confocal microscope observation, the 
platelets were labeled with CM-DiI, and the leukocytes 
were labeled with BCECF. After LSECs were seeded into a 
Petri dish and grew to 50% confluence, similar processes 
were carried out as described in the subsection of “Detec-
tion of leukocyte adhesion to endothelial cells”. The images 
were obtained by a laser scanning confocal microscope. In 
each group, five endothelial cells were randomly selected, 
and the leukocytes adhered to a single endothelial cell were 
counted. In the platelet-treated group, leukocyte direct ad-
hesion or platelet-mediated adhesion was respectively 
counted, and the ratios of the direct adherent leukocytes to 
the total adherent leukocytes were calculated. 
In the electron microscope observation, the LSECs were 
inoculated into a cell culture insert and grew to confluence. 
After the LSECs were subjected to an H-R treatment, the 
platelets were added to the top layer of the chamber and 
were co-incubated with LSECs for 4 h (platelet:LSEC= 
3,000:1). The non-adherent platelets were removed by 
three-fold washing. Then leukocytes were added (leuko-
cyte:LSEC=10:1) and co-incubated for 30 min. The 
non-adherent leukocytes were removed by washing three 
times. The samples were fixed in 1% paraformaldehyde and 
0.125% glutaraldehyde for 30 min. After three washes with 
phosphate buffered saline (PBS), the mouse anti-human 
gpIIb monoclonal antibody (final concentration of 5     
μg mL1) was added and incubated with the samples over-
night at 4°C. After three washes with PBS, the colloidal 
gold-labeled goat-anti-mouse antibody (final concentration 
of 10 nmol L1) was added. After incubation at room tem-
perature for 60 min, the samples were washed three times 
with PBS and fixed with 2.5% glutaraldehyde for 30 min. 
After three PBS washes, the samples were fixed with 1% 
osmic acid for 20 min. The cell insert was removed after 
three washes with PBS, and the membrane was taken off 
along the bottom of the insert. After dehydration, the spec-
imens were embedded in epoxy resin mixture and prepared 
for the transmission electron microscope observation. In the 
H-R group without platelet pre-incubation, the same H-R 
and co-culture procedures as described in “Detection of 
leukocyte adhesion to endothelial cells” were conducted, 
and the samples were prepared for electron microscope ob-
servation as detailed above. The images were recorded by a 
transmission electron microscope. 
Detection of leukocyte transmigration through endothe-
lial cell layer  
The HBECs, HLECs and LSECs were seeded on the inserts 
of migration chambers and grew to confluence. In the ex-
periments with platelets, the endothelial cells were subject-
ed to an H-R treatment, then the platelets were added to the 
upper layer of the migration chamber inserts, and the mix-
ture were co-cultured for 30 min (platelet:endothelial cell= 
3,000:1). The non-adherent platelets were removed by 
washing three times. BCECF-labeled leukocytes were then 
added to the top layer (leukocyte:endothelial cell=10:1), 
while 100 U mL1 interferon- (Sigma, USA) and 1,000   
U mL1 tumor necrosis factor- (TNF-; Sigma, USA) 
were added to the medium in the lower chamber. The cells 
that had passed through the migration chamber insert were 
collected 12 h later, and were centrifuged and plated in a 
96-well plate. The migrated cells were detected by a fluo-
rescence microscope and measured by a fluorescence plate 
reader. In the experiments without platelets, similar proce-
dures were conducted (as described above), except that no 
platelets were added before leukocyte co-incubation. 
Groups without H-R treatment were set as controls. 
In the antibody blocking experiments, mouse anti-human 
gpIb, gpIIb, gpIIIa, P-selectin, CD31, CD36, ICAM-1, 
VCAM-1, or ELAM-1 antibody was incubated with endo-
thelial cells before platelets or leukocytes were added (final 
concentration=5 μg mL1). The control groups were incu-
bated with unrelated IgG.  
Establishment of the mesenteric ischemia-reperfusion 
model  
Ten-week-old male Sprague-Dawley rats were purchased 
from Vital River Laboratory Animal Inc. The research pro-
tocols were reviewed and approved by the Animal Care and 
Use Review Committee of China-Japan Friendship Hospi-
tal. The present study complied with the Guide for the Care 
and Use of Laboratory Animals published by the US Na-
tional Institutes of Health (NIH publication no. 85–23, re-
vised 1996). The rat platelets were separated according to 
the method mentioned for human platelet isolation with 
minor adjustments. The rat leukocytes were separated by a 
rat leukocyte isolation kit with procedures similar to those 
for human leukocyte isolation. The platelets were labeled 
with CM-DiI, and the leukocytes were labeled with BCECF. 
The leukocytes were subjected to an H-R treatment. Then 
the platelets and leukocytes were co-incubated for 30 min 
(platelet:leukocyte=3,000:1). The samples were centri-
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fuged at 270×g for 10 min at room temperature, and the 
non-adherent platelet supernatants were discarded. 
The rats were anesthetized by a pentobarbital sodium in-
traperitoneal injection (40 mg kg1). The abdominal wall 
was incised, and one branch of mesenteric artery was 
clamped for 30 min. Then, the clamp was released, and 
1×107 leukocytes with or without platelet incubation were 
injected into the jejunal artery, allowing them to flow 
through both the ischemic-reperfused and normal-perfused 
mesenteric branches. Ten rats were treated in the acute (10 
min of reperfusion) model, and another ten were treated in 
the subacute (12 h of reperfusion) model. In the acute mod-
el, the affected vessels and their projected jejunum were 
observed under a fluorescence microscope 10 min after 
leukocyte injection. In the subacute model, the abdominal 
walls were closed after the leukocyte injection, and the rats 
were sedated by a low-dose intraperitoneal injection of 
pentobarbital sodium (15 mg kg1), which was administered 
every 4 h. Twelve hours after the leukocyte injection, the 
affected vessels and their projected jejunum were exposed 
and observed under a fluorescence microscope. 
Statistical analysis 
The data were analyzed with GraphPad Prism 5 software 
and expressed as mean±standard deviation. The differences 
between groups were compared by t-test (only two groups) 
or One-way ANOVA (more than two groups). P<0.05 was 
considered statistically significant. 
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